Template:Epidural compression syndromes management: Difference between revisions
(Created page with "==Management== #Dexamethasone: at least 16 mg IV as soon as possible after assessment<ref>Metastatic spinal cord compression: Diagnosis and management of patients at risk...") |
|||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Management== | ===General [[Epidural compression syndromes|Epidural Compression Syndrome]] Management=== | ||
*[[Dexamethasone]]: at least 16 mg IV as soon as possible after assessment<ref>Metastatic spinal cord compression: Diagnosis and management of | |||
patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer</ref> | patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer</ref> | ||
**Note: [[dexamethasone]] can be used to reduce compressive edema from epidural metastases, but is more likely to worsen an infection from spinal epidural abscess. | |||
*Consult spine service | |||
*Consider foley for bladder decompression | |||
Latest revision as of 21:33, 13 September 2018
General Epidural Compression Syndrome Management
- Dexamethasone: at least 16 mg IV as soon as possible after assessment[1]
- Note: dexamethasone can be used to reduce compressive edema from epidural metastases, but is more likely to worsen an infection from spinal epidural abscess.
- Consult spine service
- Consider foley for bladder decompression
- ↑ Metastatic spinal cord compression: Diagnosis and management of patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer